期刊文献+

新藤黄酸亲水凝胶骨架片的制备和体外释放度研究 被引量:4

Study on Neogambogic Acid Sustained-Release Tablets and in Vitro Release Characteristics
下载PDF
导出
摘要 目的研究新藤黄酸骨架片体外释药速率的影响因素。方法以羟丙甲基纤维素(HPMC)为骨架材料,考察HPMC用量、乙基纤维素(EC)用量、乳糖用量、压片压力和桨转速对药物体外释药行为的影响。结果HPMC和EC用量显著影响新藤黄酸的释药速率,乳糖用量、压片压力和桨转速的影响较小。结论通过调节HPMC和EC用量可获得具有理想释药行为的新藤黄酸亲水凝胶缓释片。 Objective To study the influential factors of the release rate of neogambogic acid from sustained release matrix tablets. Methods The influence of formulation and process variances such as the amount of HPMC, EC, lactose, compression force and rotation speed of pad- dle were investigated. Results The rate of neogambogic acid release was mainly controlled by the amount of HPMC and EC. The effects of the amount of lactose, compression force and rotation speed of paddle on the drug release were not significant. Conclusion Adjusting the amount of HPMC and EC,the neogambogic acid sustained release tablet with ideal release behavior is obtained.
出处 《中国药业》 CAS 2008年第18期22-23,共2页 China Pharmaceuticals
关键词 新藤黄酸 缓释 体外释放度 neogambog acid sustained release in vitro release characteristics
  • 相关文献

参考文献7

二级参考文献5

共引文献54

同被引文献67

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部